Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 75 of 117 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/31/09
End: 08/01/17
Due: 08/01/18
Phase: N/A
Priority: Normal
Start: 01/14/19
End: 04/30/21
Due: 04/30/22
Phase: N/A
Priority: Normal
Start: 08/11/15
End: 12/15/15
Due: 12/15/16
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 06/30/16
End: 10/31/18
Due: 10/31/19
Phase: N/A
Priority: Normal
Start: 04/30/12
End: 06/30/13
Due: 06/30/14
Phase: N/A
Priority: Normal
Start: 06/30/11
End: 11/30/11
Due: 11/30/12
Phase: N/A
Priority: Normal
Start: 12/31/11
End: 12/31/12
Due: 12/31/13
Bosentan in Myocardium Metabolism and Perfusion Measured by 18F-FDG and 82Rb PET/CT on PAH and CTEPH
Phase: N/A
Priority: Normal
Start: 04/30/13
End: 12/31/18
Due: 12/31/19
Phase: N/A
Priority: Normal
Start: 10/31/12
End: 09/30/17
Due: 09/30/18
Phase: N/A
Priority: Normal
Start: 07/31/11
End: 12/31/13
Due: 12/31/14
Phase: N/A
Priority: Normal
Start: 06/14/18
End: 03/16/20
Due: 03/16/21
Phase: N/A
Priority: Normal
Start: 09/30/10
End: 09/30/11
Due: 09/30/12
Phase: N/A
Priority: Normal
Start: 06/30/12
End: 04/30/13
Due: 04/30/14
Phase: N/A
Priority: Normal
Start: 08/01/15
End: 06/02/16
Due: 06/02/17
Phase: N/A
Priority: Normal
Start: 04/30/12
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 10/31/07
End: 04/30/09
Due: 04/30/10
Phase: N/A
Priority: Normal
Start: 07/01/23
End: 10/01/25
Due: 10/01/26
Phase: N/A
Priority: Normal
Start: 09/30/07
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 04/21/21
End: 09/19/23
Due: 09/19/24
Phase: N/A
Priority: Normal
Start: 10/31/06
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/31/12
End: 10/31/13
Due: 10/31/14
Phase: N/A
Priority: Normal
Start: 11/30/12
End: 12/30/22
Due: 12/30/23
Phase: N/A
Priority: Normal
Start: 01/31/07
End: 06/30/10
Due: 06/30/11
Phase: N/A
Priority: Normal
Start: 09/30/16
End: 10/25/21
Due: 10/25/22